Open access · CC-BY
via OpenAlex
Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition
Alessandro Bitto, Nicole Tatom, Thomas Krivak, Peter Grotz, Matt R. Kaeberlein
Frontiers in Aging · 2021 · ▲ 13 citations
Deregulated nutrient-sensing
Altered intercellular communication
Caloric restriction
Rapamycin / mTOR inhibition
Mouse
Abstract
Aging and obesity are common risk factors for numerous chronic pathologies, and the compounding effects of old age and increased adiposity pose a serious threat to public health. Starting from the assumption that aging and obesity may have shared underpinnings, we investigated the antiobesogenic potential of a successful longevity intervention, the mTORC1 inhibitor mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition). We find that rapamycin prevents diet-induced obesity in mice and increases the activity of C/EBP-β LAP, a transcription factor that regulates the metabolic shift to lipid catabolism observed in response to calorie restriction. Independent activation of C/EBP-β LAP with the antiretroviral drug adefovir dipivoxil recapitulates the anti-obesogenic effects of rapamycin without reducing signaling through mTORC1 and increases markers of fat catabolism in the liver. Our findings support a model that C/EBP-β LAP acts downstream of mTORC1 signaling to regulate fat metabolism and identifies a novel drug that may be exploited to treat obesity and decrease the incidence of age-related disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fragi.2021.738512
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Bitto, A., Tatom, N., Krivak, T., Grotz, P., & Kaeberlein, M.R. (2021). Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition. <em>Frontiers in Aging</em>. https://doi.org/10.3389/fragi.2021.738512
Vancouver
Bitto A, Tatom N, Krivak T, Grotz P, Kaeberlein MR. Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition. Frontiers in Aging. 2021. doi:10.3389/fragi.2021.738512.
BibTeX
@article{alessandro2021Eviden,
title = {Evidence that C/EBP-β LAP Increases Fat Metabolism and Protects Against Diet-Induced Obesity in Response to mTOR Inhibition},
author = {Alessandro Bitto and Nicole Tatom and Thomas Krivak and Peter Grotz and Matt R. Kaeberlein},
journal = {Frontiers in Aging},
year = {2021},
doi = {10.3389/fragi.2021.738512},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oxidative Medicine and Cellular Longevity 2018
Open access · CC-BY
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Innovation in Aging 2021
Open access · CC-BY
Geroscience approaches to obesity
Preprints.org 2021
Preprint · CC-BY
Rapamycin and Rapalogs
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · OA
Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics
Nature Communications 2022
Open access · CC-BY
Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle
Cancer Biology & Therapy 2012
Open access · OA